Skip to main content

 

Select a location

North America

  • US
  • Canada (EN | FR)

Latin America

  • Brazil
  • Colombia
  • Mexico

Asia PaCific

  • Australia
  • Japan

Europe & MENA

  • Benelux
  • Central Eastern Europe
  • France
  • Germany & Austria & Switzerland
  • Greece
  • Italy
  • Middle East & North Africa
  • Nordic & Baltic countries
  • Russia
  • Spain
  • United Kingdom
  • Global

Locations

  • Home

Countries: USA ▼

Menu utilisateur

  • Contact us
  • Foundation
Home
Home
Menu
  • About us
  • Our Focus
  • Products
  • Medical Professionals
  • Contact us - USA
  • Careers
  • Clinical Studies

Breadcrumb

  1. Home
  2. News

News

RECORDATI RARE DISEASES INC. ANNOUNCES AVAILABILITY OF ISTURISA® (OSILODROSTAT) IN THE UNITED STATES

05/27/2020
 
 

RECORDATI: ISTURISA® (OSILODROSTAT) APPROVED IN THE U.S.

03/09/2020
 
 

Recordati Rare Diseases Statement Regarding COVID-19

03/06/2020
 
 

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • …
  • Next page Next ›
  • Last page Last »

recordati logo

 

Linkedin

Informations

  • Terms of use
  • Community Guidelines
  • Corporate Compliance

® 2025 Recordati Rare Diseases Inc. All rights reserved.

Disclaimer

This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional.

All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

Always consult a physician if you have health concerns.

Use and access of this site is subject to the terms and conditions as set out in our PRIVACY POLICY and TERMS OF USE.

Other trademarks, registered or otherwise, are the property of their respective owner(s).

NP-RRD-US-0326v7

  • About us
  • Our Focus
  • Products
  • Medical Professionals
  • Contact us - USA
  • Careers
  • Clinical Studies